T1	tradename 0 7	DEPOCYT
T2	activeingredient 9 19	cytarabine
T3	nanoparticle 20 28	liposome
T4	tradename 155 162	DEPOCYT
T5	tradename 225 242	DEPOCYT. DEPOCYT
T6	activeingredient 244 254	cytarabine
T7	nanoparticle 255 263	liposome
T8	routeofadministration 280 291	Intrathecal
T9	fdaapprovaldate 325 329	1999
T10	adversereaction 443 466	Chemical arachnoiditis,
T11	adversereaction 502 529	nausea, vomiting, headache
T12	adversereaction 534 540	fever,
T13	adversereaction 613 635	chemical arachnoiditis
T14	tradename 670 677	DepoCyt
T15	co-administereddrug 714 727	dexamethasone
T16	adversereaction 757 780	chemical arachnoiditis.
T17	tradename 871 878	DepoCyt
T18	routeofadministration 900 911	intrathecal
T19	indication 925 950	lymphomatous meningitis.
T20	tradename 1027 1034	DepoCyt
T21	routeofadministration 1042 1053	intrathecal
T22	tradename 1099 1107	DepoCyt,
T23	dose 1108 1114	50 mg,
T24	routeofadministration 1126 1139	intrathecally
T25	frequency 1178 1191	every 14 days
T26	tradename 1260 1268	DepoCyt,
T27	dose 1269 1275	50 mg,
T28	routeofadministration 1287 1300	intrathecally
T29	frequency 1339 1352	every 14 days
T30	tradename 1454 1462	DepoCyt,
T31	dose 1463 1469	50 mg,
T32	routeofadministration 1481 1494	intrathecally
T33	frequency 1533 1546	every 28 days
T34	co-administereddrug 1601 1614	dexamethasone
T35	dose 1615 1619	4 mg
T36	frequency 1620 1631	twice a day
T37	routeofadministration 1639 1647	by mouth
T38	routeofadministration 1651 1664	intravenously
T39	tradename 1701 1708	DepoCyt
T40	tradename 1767 1774	DepoCyt
T41	dose 1778 1784	25 mg.
T42	tradename 1825 1833	DepoCyt.
T43	activeingredient 1973 1983	cytarabine
T44	nanoparticle 1984 1992	liposome
T45	activeingredient 2114 2124	cytarabine
T46	adversereaction 2294 2304	Myelopathy
T47	tradename 2377 2385	DepoCyt.
T48	tradename 2525 2533	DepoCyt.
T49	adversereaction 2677 2726	headache, arachnoiditis, confusion, abnormal gait
T50	adversereaction 2729 2787	convulsions, weakness, pyrexia, fatigue, nausea, vomiting
T51	adversereaction 2790 2803	constipation,
T52	adversereaction 2808 2818	back pain.
T53	company 2873 2905	Sigma-Tau Pharmaceuticals, Inc.
T54	adversereaction 3375 3397	Chemical Arachnoiditis
T55	adversereaction 4684 4706	CHEMICAL ARACHNOIDITIS
T56	adversereaction 4726 4749	Chemical arachnoiditis,
T57	adversereaction 4785 4811	nausea, vomiting, headache
T58	adversereaction 4816 4822	fever,
T59	adversereaction 4895 4917	chemical arachnoiditis
T60	tradename 4952 4959	DepoCyt
T61	co-administereddrug 4996 5009	dexamethasone
T62	adversereaction 5038 5062	chemical arachnoiditis.
T63	tradename 5131 5138	DepoCyt
T64	activeingredient 5141 5151	cytarabine
T65	nanoparticle 5152 5160	liposome
T66	routeofadministration 5193 5204	intrathecal
T67	indication 5218 5244	lymphomatous meningitis.
T68	tradename 5324 5331	DepoCyt
T69	tradename 5447 5455	DepoCyt.
T70	tradename 5493 5500	DepoCyt
T71	tradename 5721 5728	DepoCyt
T72	tradename 5786 5793	DepoCyt
T73	tradename 5976 5983	DepoCyt
T74	tradename 6053 6060	DepoCyt
T75	tradename 6123 6130	DepoCyt
T76	tradename 6366 6373	DepoCyt
T77	tradename 6480 6496	DepoCyt. DepoCyt
T78	routeofadministration 6598 6635	direct injection into the lumbar sac.
T79	tradename 6637 6644	DepoCyt
T80	indication 6929 6953	lymphomatous meningitis,
T81	tradename 6954 6961	DepoCyt
T82	dose 6962 6967	50 mg
T83	tradename 6981 6989	DepoCyt)
T84	tradename 7074 7082	DepoCyt,
T85	dose 7083 7089	50 mg,
T86	routeofadministration 7103 7116	intrathecally
T87	routeofadministration 7138 7155	lumbar puncture)
T88	frequency 7156 7169	every 14 days
T89	tradename 7222 7230	DepoCyt,
T90	dose 7231 7237	50 mg,
T91	routeofadministration 7251 7264	intrathecally
T92	routeofadministration 7286 7303	lumbar puncture)
T93	frequency 7304 7317	every 14 days
T94	tradename 7405 7413	DepoCyt,
T95	dose 7414 7420	50 mg,
T96	routeofadministration 7434 7447	intrathecally
T97	routeofadministration 7469 7486	lumbar puncture)
T98	frequency 7487 7500	every 28 days
T99	co-administereddrug 7571 7584	dexamethasone
T100	dose 7585 7589	4 mg
T101	frequency 7590 7601	twice a day
T102	routeofadministration 7609 7617	by mouth
T103	routeofadministration 7621 7634	intravenously
T104	duration 7639 7645	5 days
T105	tradename 7671 7678	DepoCyt
T106	dose 7761 7767	25 mg.
T107	tradename 7800 7807	DepoCyt
T108	activeingredient 8391 8401	cytarabine
T109	nanoparticle 8402 8410	liposome
T110	tradename 8445 8452	DepoCyt
T111	activeingredient 8455 8465	cytarabine
T112	nanoparticle 8466 8474	liposome
T113	activeingredient 8543 8553	cytarabine
T114	adversereaction 8674 8721	Chemical Arachnoiditis Chemical arachnoiditis,
T115	adversereaction 8757 8783	nausea, vomiting, headache
T116	adversereaction 8788 8794	fever,
T117	adversereaction 8847 8869	chemical arachnoiditis
T118	adversereaction 8970 8992	chemical arachnoiditis
T119	adversereaction 9038 9060	chemical arachnoiditis
T120	tradename 9134 9141	DepoCyt
T121	co-administereddrug 9178 9191	dexamethasone
T122	adversereaction 9221 9243	chemical arachnoiditis
T123	routeofadministration 9520 9531	intrathecal
T124	tradename 9545 9552	DepoCyt
T125	adversereaction 9610 9624	neurotoxicity.
T126	adversereaction 9645 9659	neurotoxicity,
T127	tradename 9687 9695	DepoCyt.
T128	tradename 9736 9743	DepoCyt
T129	adversereaction 9782 9795	Hydrocephalus
T130	adversereaction 9845 9874	arachnoiditis. Arachnoiditis
T131	routeofadministration 9960 9971	intrathecal
T132	adversereaction 10031 10044	arachnoiditis
T133	tradename 10068 10075	DepoCyt
T134	indication 10142 10166	lymphomatous meningitis.
T135	adversereaction 10201 10223	chemical arachnoiditis
T136	co-administereddrug 10263 10276	dexamethasone
T137	co-administereddrug 10307 10320	dexamethasone
T138	adversereaction 10339 10361	chemical arachnoiditis
T139	adversereaction 10399 10412	Neurotoxicity
T140	routeofadministration 10414 10425	Intrathecal
T141	activeingredient 10444 10454	cytarabine
T142	adversereaction 10465 10475	myelopathy
T143	adversereaction 10486 10505	neurologic toxicity
T144	routeofadministration 10580 10591	intrathecal
T145	activeingredient 10592 10602	cytarabine
T146	adversereaction 10715 10729	neurotoxicity.
T147	activeingredient 10781 10791	cytarabine
T148	adversereaction 10844 10858	neurotoxicity.
T149	routeofadministration 10882 10893	intrathecal
T150	routeofadministration 11023 11034	intrathecal
T151	tradename 11053 11061	DepoCyt,
T152	adversereaction 11062 11094	central nervous system toxicity,
T153	adversereaction 11105 11168	persistent extreme somnolence, hemiplegia, visual disturbances
T154	adversereaction 11179 11188	blindness
T155	adversereaction 11224 11232	deafness
T156	adversereaction 11237 11258	cranial nerve palsies
T157	adversereaction 11301 11324	peripheral neuropathy,
T158	adversereaction 11333 11371	pain, numbness, paresthesia, weakness,
T159	adversereaction 11376 11410	impaired bowel and bladder control
T160	adversereaction 11523 11545	Cauda Equina Syndrome.
T161	adversereaction 11567 11581	neurotoxicity,
T162	tradename 11609 11616	DepoCyt
T163	tradename 11632 11639	DepoCyt
T164	adversereaction 11640 11658	Headache, nausea,
T165	adversereaction 11663 11668	fever
T166	adversereaction 11700 11714	neurotoxicity.
T167	tradename 11889 11896	DepoCyt
T168	activeingredient 11941 11952	Cytarabine,
T169	tradename 11977 11985	DepoCyt,
T170	activeingredient 12090 12100	cytarabine
T171	routeofadministration 12111 12122	intrathecal
T172	tradename 12141 12148	DepoCyt
T173	activeingredient 12648 12658	Cytarabine
T174	activeingredient 12693 12703	Cytarabine
T175	adversereaction 13127 13149	Chemical Arachnoiditis
T176	adversereaction 13197 13210	Neurotoxicity
T177	adversereaction 13258 13319	Transient elevations in CSF protein and CSF white blood cells
T178	routeofadministration 13404 13415	intrathecal
T179	activeingredient 13434 13444	cytarabine
T180	adversereaction 13503 13511	headache
T181	adversereaction 13517 13533	nausea, vomiting
T182	adversereaction 13539 13632	arachnoiditis, weakness, confusion, pyrexia, fatigue, constipation, back pain, gait abnormal
T183	adversereaction 13638 13649	convulsions
T184	adversereaction 13655 13664	dizziness
T185	adversereaction 13670 13728	lethargy, pain in limb, insomnia, urinary tract infection
T186	adversereaction 13734 13750	neck pain, death
T187	adversereaction 13756 13800	pain, memory impairment, dehydration, anemia
T188	adversereaction 13806 13814	diarrhea
T189	adversereaction 13821 13839	appetite decreased
T190	adversereaction 13845 13980	thrombocytopenia, edema peripheral, arthralgia, neck stiffness, vision blurred, muscle weakness, neutropenia, hypoesthesia, agitation,
T191	adversereaction 13985 13992	dyspnea
T192	indication 14709 14732	lymphomatous meningitis
T193	tradename 14743 14750	DepoCyt
T194	dose 14751 14756	50 mg
T195	tradename 14832 14839	DepoCyt
T196	tradename 14850 14857	DepoCyt
T197	adversereaction 14908 14916	Headache
T198	adversereaction 14949 14962	Arachnoiditis
T199	adversereaction 14992 15001	Confusion
T200	adversereaction 15030 15043	Gait abnormal
T201	adversereaction 15075 15086	Convulsions
T202	adversereaction 15116 15125	Dizziness
T203	adversereaction 15156 15173	Memory impairment
T204	adversereaction 15199 15211	Hypoesthesia
T205	adversereaction 15238 15244	Tremor
T206	adversereaction 15270 15291	Peripheral neuropathy
T207	adversereaction 15319 15326	Syncope
T208	adversereaction 15351 15361	Neuropathy
T209	adversereaction 15390 15419	Peripheral sensory neuropathy
T210	adversereaction 15444 15461	Reflexes abnormal
T211	adversereaction 15541 15549	Weakness
T212	adversereaction 15579 15586	Pyrexia
T213	adversereaction 15615 15622	Fatigue
T214	adversereaction 15650 15658	Lethargy
T215	adversereaction 15685 15690	Death
T216	adversereaction 16193 16201	Lymphoma
T217	tradename 16243 16250	DepoCyt
T218	tradename 16261 16268	DepoCyt
T219	adversereaction 16293 16297	Pain
T220	adversereaction 16327 16343	Edema peripheral
T221	adversereaction 16371 16375	Fall
T222	adversereaction 16400 16420	Mucosal inflammation
T223	adversereaction 16448 16453	Edema
T224	adversereaction 16509 16515	Nausea
T225	adversereaction 16545 16553	Vomiting
T226	adversereaction 16586 16598	Constipation
T227	adversereaction 16625 16633	Diarrhea
T228	adversereaction 16664 16678	Abdominal pain
T229	adversereaction 16708 16717	Dysphagia
T230	adversereaction 16743 16754	Hemorrhoids
T231	adversereaction 16829 16838	Back pain
T232	adversereaction 16865 16877	Pain in limb
T233	adversereaction 16904 16913	Neck pain
T234	adversereaction 16940 16950	Arthralgia
T235	adversereaction 16976 16990	Neck stiffness
T236	adversereaction 17016 17031	Muscle weakness
T237	adversereaction 17084 17092	Insomnia
T238	adversereaction 17119 17128	Agitation
T239	adversereaction 17154 17164	Depression
T240	adversereaction 17190 17197	Anxiety
T241	adversereaction 17251 17274	Urinary tract infection
T242	adversereaction 17305 17314	Pneumonia
T243	adversereaction 17379 17390	Dehydration
T244	adversereaction 17417 17435	Appetite decreased
T245	adversereaction 17466 17478	Hyponatremia
T246	adversereaction 17503 17514	Hypokalemia
T247	adversereaction 17539 17552	Hyperglycemia
T248	adversereaction 17577 17585	Anorexia
T249	adversereaction 17626 17650	Platelet count decreased
T250	adversereaction 17704 17716	Incontinence
T251	adversereaction 17745 17762	Urinary retention
T252	adversereaction 17837 17844	Dyspnea
T253	adversereaction 17875 17880	Cough
T254	adversereaction 17920 17934	Vision blurred
T255	adversereaction 17992 17998	Anemia
T256	adversereaction 18029 18045	Thrombocytopenia
T257	tradename 18567 18574	DepoCyt
T258	tradename 18585 18592	DepoCyt
T259	adversereaction 18617 18628	Neutropenia
T260	adversereaction 18697 18706	Contusion
T261	adversereaction 18731 18739	Pruritus
T262	adversereaction 18767 18785	Sweating increased
T263	adversereaction 18830 18841	Hypotension
T264	adversereaction 18870 18882	Hypertension
T265	adversereaction 18940 18949	Hypacusis
T266	adversereaction 18994 19005	Tachycardia
T267	adversereaction 19104 19133	Diffuse Large B-Cell Lymphoma
T268	tradename 19305 19312	DepoCyt
T269	dose 19313 19318	50 mg
T270	tradename 19346 19353	DepoCyt
T271	adversereaction 19450 19458	Headache
T272	adversereaction 19491 19504	Arachnoiditis
T273	adversereaction 19534 19545	Convulsions
T274	adversereaction 19604 19620	Nausea Vomiting
T275	adversereaction 19743 19779	Back pain Neck pain Neck stiffness
T276	adversereaction 19836 19843	Pyrexia
T277	tradename 20091 20098	DepoCyt
T278	adversereaction 20155 20161	deaths
T279	tradename 20173 20180	DepoCyt
T280	dose 20215 20221	125 mg
T281	adversereaction 20242 20256	encephalopathy
T282	routeofadministration 20285 20301	intraventricular
T283	tradename 20310 20318	DepoCyt.
T284	tradename 20485 20493	DepoCyt,
T285	dose 20494 20499	50 mg
T286	routeofadministration 20507 20523	intraventricular
T287	adversereaction 20544 20559	focal seizures
T288	adversereaction 20575 20594	status epilepticus.
T289	adversereaction 20736 20744	seizures
T290	tradename 20763 20770	DepoCyt
T291	activeingredient 20804 20814	cytarabine
T292	adversereaction 20839 20844	death
T293	tradename 20907 20915	DepoCyt.
T294	tradename 21593 21601	DepoCyt.
T295	tradename 21696 21703	DepoCyt
T296	tradename 21773 21780	DepoCyt
T297	routeofadministration 21835 21846	intrathecal
T298	routeofadministration 21880 21891	intrathecal
T299	activeingredient 21892 21902	cytarabine
T300	routeofadministration 21944 21958	intrathecally,
T301	adversereaction 21968 21981	neurotoxicity
T302	tradename 22203 22211	DepoCyt.
T303	activeingredient 22237 22247	cytarabine
T304	routeofadministration 22259 22270	intrathecal
T305	tradename 22289 22296	DepoCyt
T306	activeingredient 22312 22322	Cytarabine
T307	activeingredient 22524 22535	cytarabine,
T308	tradename 22691 22699	DepoCyt.
T309	activeingredient 22878 22888	Cytarabine
T310	dose 22997 23012	&#x2265;2 mg/kg
T311	frequency 23012 23016	/day
T312	routeofadministration 23035 23037	IP
T313	dose 23176 23184	20 mg/kg
T314	routeofadministration 23215 23217	IP
T315	routeofadministration 23316 23318	IP
T316	dose 23328 23336	50 mg/kg
T317	activeingredient 23523 23533	Cytarabine
T318	dose 23676 23685	0.5 mg/kg
T319	frequency 23685 23689	/day
T320	dose 23831 23838	8 mg/kg
T321	frequency 23838 23842	/day
T322	activeingredient 23959 23969	cytarabine
T323	routeofadministration 24006 24017	intrathecal
T324	tradename 24018 24025	DepoCyt
T325	activeingredient 24073 24083	cytarabine
T326	routeofadministration 24094 24105	intrathecal
T327	tradename 24121 24128	DepoCyt
T328	tradename 24467 24474	DepoCyt
T329	tradename 24628 24635	DepoCyt
T330	tradename 24695 24702	DepoCyt
T331	activeingredient 24705 24715	cytarabine
T332	nanoparticle 24716 24724	liposome
T333	tradename 24775 24782	DepoCyt
T334	adversereaction 24813 24835	chemical arachnoiditis
T335	adversereaction 24846 24861	encephalopathy.
T336	co-administereddrug 24903 24916	dexamethasone
T337	dose 24949 24955	125 mg
T338	routeofadministration 25014 25025	intrathecal
T339	tradename 25026 25033	DepoCyt
T340	activeingredient 25052 25062	cytarabine
T341	tradename 25077 25085	DepoCyt.
T342	routeofadministration 25158 25169	intrathecal
T343	activeingredient 25187 25198	cytarabine,
T344	tradename 25255 25262	DepoCyt
T345	tradename 25750 25757	DepoCyt
T346	activeingredient 25760 25770	cytarabine
T347	nanoparticle 25771 25779	liposome
T348	chemoclass 25834 25848	antimetabolite
T349	activeingredient 25849 25859	cytarabine
T350	routeofadministration 25865 25876	intrathecal
T351	activeingredient 25915 25925	cytarabine
T352	molecularweight 26084 26097	243.22 g/mol.
T353	activeingredient 26098 26108	Cytarabine
T354	tradename 26148 26155	DepoCyt
T355	activeingredient 26227 26238	cytarabine.
T356	tradename 26239 26246	DepoCyt
T357	activeingredient 26324 26334	cytarabine
T358	nanoparticle 26335 26344	liposomes
T359	inactiveingredient 26358 26373	sodium chloride
T360	inactiveingredient 26377 26382	water
T361	activeingredient 26422 26433	cytarabine,
T362	corecomposition 26441 26453	cholesterol,
T363	corecomposition 26479 26514	dioleoylphosphatidylcholine (DOPC),
T364	corecomposition 26526 26565	dipalmitoylphosphatidylglycerol (DPPG).
T365	tradename 26566 26573	DepoCyt
T366	nanoparticle 26660 26668	Liposome
T367	activeingredient 26748 26758	cytarabine
T368	nanoparticle 26760 26768	liposome
T369	activeingredient 26865 26876	cytarabine.
T370	tradename 26930 26937	DepoCyt
T371	activeingredient 26940 26950	cytarabine
T372	nanoparticle 26951 26959	liposome
T373	activeingredient 27032 27042	cytarabine
T374	activeingredient 27114 27124	Cytarabine
T375	activeingredient 27255 27265	cytarabine
T376	activeingredient 27284 27295	cytarabine-
T377	activeingredient 27545 27555	cytarabine
T378	activeingredient 27571 27581	Cytarabine
T379	routeofadministration 27674 27685	intrathecal
T380	tradename 27704 27711	DepoCyt
T381	dose 27712 27718	50 mg,
T382	activeingredient 27743 27753	cytarabine
T383	tmax 27769 27782	within 1 hour
T384	cmax 27809 27825	30 to 50 mcg/mL.
T385	activeingredient 27867 27877	cytarabine
T386	plasmahalflife 27893 27911	5.9 to 82.4 hours.
T387	activeingredient 27933 27943	cytarabine
T388	routeofadministration 27970 27981	intrathecal
T389	tradename 28000 28007	DepoCyt
T390	dose 28008 28014	50 mg.
T391	activeingredient 28080 28090	cytarabine
T392	activeingredient 28219 28230	cytarabine,
T393	routeofadministration 28322 28333	intrathecal
T394	activeingredient 28468 28478	cytarabine
T395	tradename 28712 28720	DepoCyt.
T396	activeingredient 28722 28732	Cytarabine
T397	activeingredient 29422 29432	Cytarabine
T398	activeingredient 29548 29558	cytarabine
T399	activeingredient 29605 29615	Cytarabine
T400	routeofadministration 29757 29759	IP
T401	activeingredient 29760 29771	cytarabine.
T402	activeingredient 29810 29820	cytarabine
T403	routeofadministration 29832 29843	intrathecal
T404	tradename 29859 29866	DepoCyt
T405	tradename 29933 29940	DepoCyt
T406	tradename 29984 29991	DepoCyt
T407	activeingredient 29993 30003	cytarabine
T408	dose 30297 30302	50 mg
T409	tradename 30306 30313	DepoCyt
T410	frequency 30327 30340	every 2 weeks
T411	routeofadministration 30353 30364	intrathecal
T412	frequency 30392 30404	twice a week
T413	dose 30518 30523	50 mg
T414	activeingredient 30542 30552	cytarabine
T415	frequency 30559 30572	twice a week.
T416	tradename 30609 30617	DepoCyt,
T417	activeingredient 30621 30632	cytarabine)
T418	tradename 31482 31489	DepoCyt
T419	tradename 31709 31716	DepoCyt
T420	activeingredient 31743 31753	cytarabine
T421	tradename 32117 32124	DepoCyt
T422	activeingredient 32128 32139	cytarabine.
T423	tradename 32189 32196	DepoCyt
T424	duration 32197 32202	50 mg
T425	frequency 32204 32217	every 2 weeks
T426	activeingredient 32221 32231	cytarabine
T427	dose 32232 32237	50 mg
T428	frequency 32238 32251	twice weekly.
T429	tradename 32303 32310	DepoCyt
T430	dose 32311 32316	50 mg
T431	frequency 32317 32331	every 4 weeks,
T432	activeingredient 32335 32345	cytarabine
T433	dose 32346 32351	50 mg
T434	frequency 32352 32358	weekly
T435	duration 32363 32371	4 weeks.
T436	co-administereddrug 32434 32447	dexamethasone
T437	adversereaction 32485 32507	chemical arachnoiditis
T438	indication 32734 32757	lymphomatous meningitis
T439	indication 32840 32863	Lymphomatous Meningitis
T440	tradename 32866 32873	DepoCyt
T441	activeingredient 32875 32885	Cytarabine
T442	tradename 33393 33400	DepoCyt
T443	activeingredient 33403 33413	cytarabine
T444	nanoparticle 33414 33422	liposome
T445	tradename 33770 33777	DepoCyt
T446	adversereaction 33977 34004	headache, nausea, vomiting,
T447	adversereaction 34009 34015	fever,
T448	adversereaction 34058 34072	neurotoxicity.
T449	co-administereddrug 34132 34145	dexamethasone
T450	tradename 34217 34224	DepoCyt
T451	co-administereddrug 34316 34329	neurotoxicity
T452	routeofadministration 34345 34349	oral
T453	co-administereddrug 34351 34364	dexamethasone
T454	company 34426 34457	Sigma-Tau Pharmaceuticals, Inc.
T455	company 34499 34528	Pacira Pharmaceuticals, Inc.,
T456	company 34567 34599	Sigma-Tau Pharmaceuticals, Inc.,
T457	u.s.patent 34643 34685	5,807,572 5,723,147 5,455,044 5,891,467
